Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

AMA, states sue Trump administration over Title X changes

The American Medical Association (AMA) filed suit against the Trump administration after it finalized changes to Title X that impact family planning providers.

Thumbnail

Amazon-Berkshire-JPMorgan healthcare joint venture will be called Haven

The healthcare joint venture between Amazon, Berkshire Hathaway and JPMorgan Chase finally has a name: Haven.

Thumbnail

Free-standing ED prices substantially higher than other care settings

Consumers are more into convenient options when it comes to just about any industry, but in healthcare, the preference has led to national growth in freestanding emergency departments (FSEDs).

Thumbnail

Patients more likely to switch hospitals to give birth if they receive a surprise bill

Mothers who gave birth twice were more likely to switch to another hospital after the first birth if they received a surprise bill following care, according to a recent study published in Health Affairs.

Thumbnail

Cigna CEO regretted deal with Anthem before it fell apart

In the midst of breakup woes that include a court fight, the failed merger between Cigna and Anthem apparently weighed heavily on the mind of Cigna’s CEO, David Cordani, before it even fell apart. According to Bloomberg, Cordani privately expressed regret he had agreed to the deal that would have left him in a reduced role.

Thumbnail

AI in medicine market projected to exceed $18B by 2025

A report released by Portland-based firm Big Market Research on March 6 projects the artificial intelligence in medicine market will grow to $18.12 billion by 2025, advancing at a compound annual growth rate (CAGR) of 49.6 percent.

Thumbnail

FDA Commissioner Scott Gottlieb resigns

FDA Commissioner Scott Gottlieb is resigning. Gottlieb has manned the agency since May 2017 and will leave his position in about a month.

Thumbnail

40% of European AI startups don’t actually use AI

Forty percent of so-called AI startups in Europe don’t actually use AI programs in their products, the Financial Times reported March 4.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup